Boldenone Undecylenate 250mg/ml 10ml Vial by Nassa Labs

Usage

1. Map your full stack before the first injection: list each compound, its dose, and injection frequency — confirm that boldenone undecylenate at 250mg/ml contributes a non-overlapping mechanism to every other agent in the protocol.
2. Draw the boldenone dose using a fresh 18–21 gauge needle through the vial's rubber stopper; inspect the drawn solution for particulates before switching to a 23–25 gauge injection needle.
3. Administer intramuscularly into the glute, quad, or delt — rotate sites across weekly injections to prevent local tissue accumulation, particularly relevant in longer stacks where injection volume per site compounds over weeks.
4. If combining with a short-ester compound (e.g. testosterone propionate, masteron propionate), align the boldenone injection to the twice-weekly short-ester schedule — this simplifies administration without altering boldenone's pharmacokinetic curve.
5. Record each injection date, site, compound drawn, and volume in a cycle log; cross-reference with haematocrit and estradiol values from bloodwork panels at weeks 4 and 8 to validate the stack's tolerability before continuing.
6. At cycle conclusion, allow sufficient clearance time for the undecylenate ester before starting PCT — coordinate with the stack's longest-ester compound to determine the latest endpoint for PCT initiation.

Warnings

Frequently asked questions

Which steroids combine most effectively with Nassa Labs Boldenone Undecylenate 250mg/ml in a stack?

Testosterone enanthate or cypionate is the most universally recommended base when stacking with boldenone undecylenate, as it covers androgenic support while boldenone contributes lean-mass accrual and haematocrit elevation independently. For a drier, more defined outcome, masteron enanthate is frequently added as a third compound. Trenbolone enanthate pairs with boldenone in advanced off-season stacks, though combined androgenic load must be monitored carefully.

What is the pharmacological reason boldenone undecylenate stacks well with masteron rather than duplicating its effects?

Boldenone undecylenate and masteron enanthate act through complementary mechanisms: boldenone drives nitrogen retention, erythropoietin-stimulated red blood cell production, and appetite upregulation, while masteron contributes anti-estrogenic activity and hardening via SHBG binding reduction. Because their receptor interactions and downstream effects differ substantially, the two compounds add non-overlapping signals to a stack rather than competing for the same physiological outputs.

How do I structure a three-compound boldenone stack to manage haematocrit safely?

Begin with a conservative boldenone dose of 300mg/week alongside testosterone at 300mg/week, scheduling haematocrit blood panels at weeks 4 and 8. The widely cited community safety ceiling is 52% haematocrit — exceeding this threshold warrants dose reduction or donation of whole blood under medical supervision. Adding a third compound such as masteron does not significantly worsen haematocrit but testosterone dose directly influences the combined erythropoietic burden.

How should Nassa Labs Boldenone Undecylenate 250mg/ml 10ml vial be stored after the first puncture?

After the rubber stopper is first punctured, the vial should be stored upright at room temperature between 20–25°C, away from direct light and heat sources. Most multi-dose vial preparations maintain sterility and potency for 28 days after first use when stored correctly. Refrigeration at 2–8°C is acceptable but not required; if the oil clouds at refrigerator temperature, allow it to reach room temperature before drawing a dose.

Can a 1ml insulin syringe be used to draw doses from the Nassa Labs 250mg/ml 10ml vial for precise stack volume control?

A standard 1ml insulin syringe can draw up to 1ml, equating to 250mg at this concentration — sufficient for a single weekly injection if the total weekly dose is 250mg. For doses above 250mg, a standard 2–3ml luer-lock syringe is more practical. Regardless of syringe type, use a separate 18–21 gauge drawing needle to puncture the stopper cleanly, then switch to a 23–25 gauge injection needle to minimise tissue trauma. (2) angle_used

Manufacturer

Nassa Labs entered the commercial injectable market by establishing a documentation-first production philosophy: every vial released under the Nassa Labs label carries a traceable lot number linked to both its HPLC content assay record and its LAL endotoxin test certificate, generated from the same production batch rather than interpolated from reference data. This approach was conceived to address a recurring concern in the community-sourced injectable market — the gap between labelled concentration and actual API content — by making analytical results batch-specific and publicly traceable rather than brand-wide assertions. The Boldenone Undecylenate 250mg/ml vial sits within a product range that shares this same lot-traceability architecture, meaning the 250mg/ml figure printed on the label reflects a measured result from that specific production run.